RxDoctor Payments Data

Justin Yeh, MD

Family Medicine · Evansville, INNPI 1114376662

Payments from drug & device makers

$8,722in general payments, 2019–2025

Across 544 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$772
  • Otsuka America Pharmaceutical, Inc.$761
  • Novo Nordisk$722
  • GSK$554
  • AstraZeneca$520
  • plus $4K from 53 others

What the payments were for

  • Food & beverage$8,722100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)97$1,284
Amgen56$772
Otsuka America Pharmaceutical, Inc.45$761
Novo Nordisk48$722
GSK35$554
AstraZeneca21$520
Axsome Therapeutics, Inc.27$442
Pfizer24$397
Lilly USA, LLC18$280
Johnson & Johnson16$262
Boehringer Ingelheim15$207
Merck14$196
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$173
Takeda Pharmaceuticals U.S.A., Inc.13$166
Sumitomo Pharma America, Inc.8$156
Biohaven Pharmaceutical Holding Company Ltd.6$122
Biogen3$111
Lundbeck LLC6$106
Inari Medical, Inc.2$105
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$93
Abbott3$90
Teva Pharmaceuticals USA, Inc.5$77
Astellas Pharma US Inc5$74
Novartis5$69
E.r. Squibb & Sons, L.L.C.4$69
Tris Pharma Inc4$68
Phathom Pharmaceuticals, Inc.4$60
Exact Sciences4$56
Mylan Specialty L.p.3$56
Corium, LLC4$55
Vanda Pharmaceuticals Inc.2$44
Inspire Medical Systems, Inc.2$40
Boston Scientific2$39
Biohaven Pharmaceuticals, Inc.2$38
Eisai Inc.1$35
Gilead1$35
Esperion Therapeutics, Inc.2$32
Dynavax Technologies Corporation2$31
Antares Pharma, Inc.2$30
Neurocrine Biosciences, Inc.1$20
CMP Pharma, Inc.1$18
Sunovion Pharmaceuticals Inc.1$18
Arbor Pharmaceuticals, Inc.1$17
Hologic Sales And Service, LLC1$17
Kowa Pharmaceuticals America, Inc.1$16
Dexcom, Inc.1$16
Viatris Specialty LLC1$15
Shield Therapeutics Inc1$15
Almatica Pharma LLC1$15
Bayer1$14
Genentech USA, Inc.1$14
Idorsia Pharmaceuticals US Inc1$13
Ironwood Pharmaceuticals, Inc1$13
Shire North American Group Inc1$13
Nevro Corp.1$13
Medtronic1$12
Amarin Pharma, Inc.1$11
Ironshore Pharmaceuticals Inc.1$11
Amneal Pharmaceuticals LLC1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,722 in reported general payments places this provider in the 90th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$229,850
Medicare patients
578
Services billed
2,853

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide78$75,373
FarxigaDapagliflozin Propanediol54$54,649
EliquisApixaban37$29,492
JanuviaSitagliptin Phosphate17$24,803
NuedextaDextromethorphan Hbr/Quinidine11$17,033
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$14,654
Tresiba Flextouch U-100Insulin Degludec22$12,757
Breo ElliptaFluticasone/Vilanterol26$10,583
TrulicityDulaglutide11$10,239
TradjentaLinagliptin17$7,675
Semglee (Yfgn) PenInsulin Glargine-Yfgn12$7,434
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$6,136
Insulin Lispro Kwikpen U-100Insulin Lispro19$5,479
DexilantDexlansoprazole13$3,938
Lurasidone Hcl16$3,688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$722$75,37378 claims
AstraZenecaFarxiga, Breztri Aerosphere$520$69,30369 claims
PfizerEliquis, Prempro$397$33,05948 claims
MerckJanuvia$196$24,80317 claims
GSKBreo Ellipta$554$10,58326 claims
Lilly USA, LLCTrulicity$280$10,23911 claims
Boehringer IngelheimTradjenta$207$7,67517 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$166$3,93813 claims
AbbVieSynthroid$1,284$2,50833 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$11$1,626210 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Evansville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →